RCP
GNVC

Rho Capital Partners’s GenVec, Inc. GNVC Stock Holding History

Rho Capital Partners’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,804
Closed -$42K – 7
2013
Q4 		$42K Hold
1,804
– – 0.02% 4
2013
Q3 		$24K Hold
1,804
– – 0.01% 5
2013
Q2 		$7K Buy
+1,804
New +$15.2K 0.01% 5

Other funds holding GNVC

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rho Capital Partners's GNVC Position: Q1 2014 in Review

Rho Capital Partners sold out of GenVec, Inc. (GNVC) in Q1 2014, closing a stake of 1,804 shares — an estimated $42K sold.

Rho Capital Partners first reported a position in GNVC in Q2 2013 and held it in 3 quarters. The position peaked at $42K in Q4 2013. 24 funds tracked by Wall St. Rank hold GNVC as of Q1 2014.

  • Rho Capital Partners reported no remaining GenVec, Inc. position as of Q1 2014 after selling out during the quarter.
  • Rho Capital Partners sold 1,804 GenVec, Inc. shares in Q1 2014, an estimated $42K.
  • Rho Capital Partners first reported a position in GenVec, Inc. in Q2 2013 and held it in 3 quarters.
  • Rho Capital Partners's GenVec, Inc. position peaked at $42K in Q4 2013.
  • 24 funds tracked by Wall St. Rank held GenVec, Inc. as of Q1 2014.

Based on Rho Capital Partners's 13F filing for Q1 2014, filed 13 May 2014.